R, N., J, A., SK, D., C, O., A, C., L, G., . . . PJ, O. (2025). Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA network open, 8(10), e2536100. https://doi.org/10.1001/jamanetworkopen.2025.36100
Chicago Style (17th ed.) CitationR, Neugebauer, et al. "Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes." JAMA Network Open 8, no. 10 (2025): e2536100. https://doi.org/10.1001/jamanetworkopen.2025.36100.
MLA (9th ed.) CitationR, Neugebauer, et al. "Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes." JAMA Network Open, vol. 8, no. 10, 2025, p. e2536100, https://doi.org/10.1001/jamanetworkopen.2025.36100.